Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
The merger brings together Labguru’s data management and ELN technologies with Mosaic’s automation and orchestration capabilities.
A recent court ruling excluding LDTs from FDA regulation highlights the urgent need for the diagnostics industry to modernize oversight.
COLA Inc. is rebranding as the Commission on Laboratory Accreditation (COLA) to better reflect its mission promoting laboratory excellence.
A federal court ruled in favor of AMP, striking down the FDA’s attempt to regulate laboratory-developed tests (LDTs) as medical devices.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Access Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Scientists have documented a notable case of antibiotic resistance evolving within a critically ill patient during treatment for an E. coli bloodstream infection, providing genomic evidence of how drug resistance can emerge in real time.